Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Mert Aktar files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Karen Marie Walker - $293K in KYTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Mert Aktar?
Mert Aktar is a corporate insider of Kyverna Therapeutics, Inc. (KYTX). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Mert Aktar last file a Form 4?
The most recent primary Form 4 on record is dated 29 May 2026, one of 2 filings going back to 2024.
